Hydroxychloroquine serum concentrations in non-critical care patients infected with SARS-CoV-2
Abstract
Hydroxychloroquine(HCQ) has been widely used to treat SARS-CoV-2 infection however HCQ pharmacokinetics in this condition have not been studied in non-critical care patient groups. Here we report the serum concentrations of HCQ in a small cohort of patients treated with HCQ as part of the RECOVERY trial.
Related articles
Related articles are currently not available for this article.